Javier Rodríguez

862 total citations
20 papers, 351 citations indexed

About

Javier Rodríguez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Javier Rodríguez has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Javier Rodríguez's work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Javier Rodríguez is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Javier Rodríguez collaborates with scholars based in Spain, United States and Italy. Javier Rodríguez's co-authors include Jesús García‐Foncillas, Emiliano Calvo, Antonio Brugarolas, Javier Cortés, Salvador Martín‐Algarra, José Manuel Aramendía, Javier Aristu, Alfonso Gúrpide, Esteban Salgado and José M. López-Picazo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Javier Rodríguez

18 papers receiving 342 citations

Peers

Countries citing papers authored by Javier Rodríguez

Since Specialization

Citations

This map shows the geographic impact of Javier Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Rodríguez more than expected).

Fields of papers citing papers by Javier Rodríguez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Rodríguez. The network helps show where Javier Rodríguez may publish in the future.

Co-authorship network of co-authors of Javier Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Rodríguez. A scholar is included among the top collaborators of Javier Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Rodríguez. Javier Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complement Factor I Deficiency With Acute Hemorrhagic Leukoencephalitis and Longitudinally Extensive Transverse Myelitis 2025 ·Neurology Neuroimmunology & Neuroinflammation ·Tiffany Hu, Javier Rodríguez, Lara Zimmermann, (unknown), (unknown), (unknown), Jeong Han Lee, Joseph Shen, (unknown), (unknown), S. S. Sidhu, (unknown), Ariane Soldatos, Jeffrey M. Gelfand, Michael R. Wilson, (unknown)	0
2	HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 2024 ·Nature Communications ·Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, Kensei Yamaguchi, Tomohiro Nishina, Élena Elez, Javier Rodríguez, Ian Chau, Maria Di Bartolomeo, Hisato Kawakami, Fumitaka Suto, (unknown), Koichiro Inaki, (unknown), (unknown), Daniel Barrios, Kojiro Kobayashi, Axel Grothey, Takayuki Yoshino	15
3	Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery 2023 ·Clinical & Translational Oncology ·Gabriel Zozaya, Javier A. Cienfuegos, Pablo Martí‐Cruchaga, José Luís Hernández-Lizoáin, Jorge Baixauli, Fernando Pardo, (unknown), Javier Rodríguez, Leire Arbea, Fernando Rotellar	3
4	Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit 2022 ·Journal of Clinical Medicine ·(unknown), Félix Alegre, Javier Rodríguez, Manuel F. Landecho, (unknown), Alfonso Gúrpide, Ramón Lecumberri, Eva Sanz, Nicolás Garcı́a, Jorge Quiroga, (unknown)	1
5	Percepción sobre la estrategia nacional para la educación física de calidad en México 2022 ·(unknown), (unknown), Javier Rodríguez, (unknown), (unknown)	1
6	Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC): Final results from a phase 2, multicenter, open-label study (DESTINY-CRC01). 2022 ·Journal of Clinical Oncology ·Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, Toshiki Masuishi, Hisato Kawakami, Kensei Yamaguchi, (unknown), Zev A. Wainberg, Élena Elez, Javier Rodríguez, Marwan Fakih, Fortunato Ciardiello, Kapil Saxena, Kojiro Kobayashi, Emarjola Bako, Yasuyuki Okuda, (unknown), Axel Grothey, Salvatore Siena	20
7	Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse 2019 ·Cancers ·(unknown), (unknown), Kenneth H. Yu, (unknown), (unknown), Omar Carranza, (unknown), Mariano Ponz‐Sarvisé, (unknown), Fernando Rotellar, (unknown), (unknown), (unknown), Alberto Benito, Fernando Pardo, Javier Rodríguez	27
8	TRAPEROS DE EMAÚS: ECONOMÍA CIRCULAR… Y SOLIDARIA 2018 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Javier Rodríguez	1
9	Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer 2016 ·British Journal of Cancer ·P. Martin Romano, J. Solà, Juan A. Díaz-González, Á. Chopitea, (unknown), Fernando Martínez-Regueira, Mariano Ponz‐Sarvisé, Leire Arbea, João Subtil, David Cano, (unknown), (unknown), Jose Luis Hernández‐Davó, Javier Rodríguez	33
10	SIRFLOX: Differences in site of first progression between mFOLFOX6 ± bevacizumab (bev) versus mFOLFOX6 ± bev + selective internal radiation therapy (SIRT) in first-line patients (pts) with metastatic colorectal cancer (mCRC). 2016 ·Journal of Clinical Oncology ·Peter Gibbs, Volker Heinemann, Navesh Sharma, Michael Findlay, Jens Ricke, Marc Peeters, D Díaz Pérez, Bridget A. Robinson, Andrew Strickland, Tom Ferguson, Javier Rodríguez, Hendrik Kroening, Ido Wolf, Vinod Ganju, Euan Walpole, Éveline Boucher, Thomas Tichler, Val Gebski, Mark Van Buskirk, Guy A. Van Hazel	0
11	Metastatic Basosquamous Carcinoma 2016 ·International Journal of Surgical Pathology ·(unknown), Angela Santoro, Giuseppe Pannone, Javier Rodríguez, (unknown), Pier Francesco Nocini	3
12	Prognosis Factors for Recurrence in Patients With Locally Advanced Rectal Cancer Preoperatively Treated With Chemoradiotherapy and Adjuvant Chemotherapy 2013 ·Diseases of the Colon & Rectum ·Jorge Arredondo, Jorge Baixauli, Carmen Beorlegui, Leire Arbea, Javier Rodríguez, J. Solà, Á. Chopitea, José Luís Hernández-Lizoáin	32
13	KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients 2013 ·Oncology Letters ·(unknown), Javier Rodríguez, Ana Patiño‐García, Jesús García‐Foncillas, Josefa Salgado	10
14	Extended Transcaruncular Approach Using Detachment and Repositioning of the Inferior Oblique Muscle for the Traumatic Repair of the Medial Orbital Wall 2009 ·Craniomaxillofacial Trauma & Reconstruction ·Javier Rodríguez, Ramón Galán, (unknown), (unknown), (unknown), (unknown), (unknown)	14
15	Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer 2005 ·Clinical & Translational Oncology ·Ignacio Gil‐Bazo, (unknown), (unknown), Javier Rodríguez, José A. Páramo, (unknown), (unknown), Jesús García‐Foncillas	17
16	Paclitaxel, Cisplatin, and Vinorelbine Combination Chemotherapy in Metastatic Non–Small-Cell Lung Cancer 2004 ·American Journal of Clinical Oncology ·Javier Cortés, Javier Rodríguez, Emiliano Calvo, Alfonso Gúrpide, Jesús García‐Foncillas, Esteban Salgado, José Manuel Aramendía, José M. López-Picazo, Berta Hernández, (unknown), Javier Aristu, Antonio Brugarolas, Salvador Martín‐Algarra	4
17	Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal Cancer 2002 ·Oncology ·Emiliano Calvo, Javier Cortés, María González‐Cao, Javier Rodríguez, José Manuel Aramendía, (unknown), Salvador Martín‐Algarra, (unknown), Rafael Martínez‐Monge, Jokin de Irala, Antonio Brugarolas	17
18	Irinotecan, Oxaliplatin, and 5-Fluorouracil/Leucovorin Combination Chemotherapy in Advanced Colorectal Carcinoma: A Phase II Study 2002 ·Clinical Colorectal Cancer ·Emiliano Calvo, Javier Cortés, Javier Rodríguez, (unknown), (unknown), Salvador Martín‐Algarra, Jesús García‐Foncillas, Rafael Martínez‐Monge, Jokin de Irala, Antonio Brugarolas	33
19	Front-Line Paclitaxel/Cisplatin-Based Chemotherapy in Brain Metastases from Non-Small-Cell Lung Cancer 2002 ·Oncology ·Javier Cortés, Javier Rodríguez, José Manuel Aramendía, Esteban Salgado, Alfonso Gúrpide, Jesús García‐Foncillas, Javier Aristu, (unknown), Ana Bosch, José M. López-Picazo, Salvador Martín‐Algarra, Antonio Brugarolas, Emiliano Calvo	110
20	Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma 2000 ·Cancer ·Javier Rodríguez, Javier Cortés, Emiliano Calvo, (unknown), (unknown), Rafael Martínez‐Monge, (unknown), Jokin de Irala, (unknown), Teresa Ramón y Cajal, Antonio Brugarolas	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact